Hepatitis B virus S gene therapy with 10-23 DNAzyme delivered by chitosan-g-stearic acid micelles

Yun Hong, Dongsen Mao, Rui Wu, Zhe Gao, Tingting Meng, Rongrong Wang, Lin Liu, Jing Miao
2019 RSC Advances  
DrzBS, which targets HBV S gene expression, has important research significance and potential application value. CSO-SA is a safe and efficient non-viral gene carrier and CSO-SA/DrzBS micelles are a promising application for anti-HBV gene therapy.
doi:10.1039/c9ra00330d fatcat:3detzc7lnrej5iaywvrf7jwhya